» Articles » PMID: 39180117

Predicting High Blood Pressure Using Machine Learning Models in Low- and Middle-income Countries

Overview
Publisher Biomed Central
Date 2024 Aug 23
PMID 39180117
Authors
Affiliations
Soon will be listed here.
Abstract

Responding to the rising global prevalence of noncommunicable diseases (NCDs) requires improvements in the management of high blood pressure. Therefore, this study aims to develop an explainable machine learning model for predicting high blood pressure, a key NCD risk factor, using data from the STEPwise approach to NCD risk factor surveillance (STEPS) surveys. Nationally representative samples of adults aged 18-69 years were acquired from 57 countries spanning six World Health Organization (WHO) regions. Data harmonization and processing were performed to standardize the selected predictors and synchronize features across countries, yielding 41 variables, including demographic, behavioural, physical, and biochemical factors. Five machine learning models - logistic regression, k-nearest neighbours, random forest, XGBoost, and a fully connected neural network - were trained and evaluated at global, regional, and country-specific levels using an 80/20 train-test split. The models' performance was assessed using accuracy, precision, recall, and F1 score. Feature importance analysis identified age, weight, heart rate, waist circumference, and height as key predictors of blood pressure. Across the 57 countries studied, model performances varied considerably, with accuracy ranging from as low as 58.96% in some models for specific countries to as high as 81.41% in others, underscoring the need for region and country-specific adaptations in modelling approaches. The explainable model offers an opportunity for population-level screening and continuous risk assessment in resource-limited settings.

References
1.
Wu X, Yuan X, Wang W, Liu K, Qin Y, Sun X . Value of a Machine Learning Approach for Predicting Clinical Outcomes in Young Patients With Hypertension. Hypertension. 2020; 75(5):1271-1278. DOI: 10.1161/HYPERTENSIONAHA.119.13404. View

2.
Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T . The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. Am J Public Health. 2015; 106(1):74-8. PMC: 4695948. DOI: 10.2105/AJPH.2015.302962. View

3.
Aikaeli F, Njim T, Gissing S, Moyo F, Alam U, Mfinanga S . Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis. PLOS Glob Public Health. 2023; 2(6):e0000599. PMC: 10021817. DOI: 10.1371/journal.pgph.0000599. View

4.
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P . The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018; 18(1):975. PMC: 6090747. DOI: 10.1186/s12889-018-5806-x. View

5.
Islam S, Talukder A, Awal M, Siddiqui M, Ahamad M, Ahammed B . Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries. Front Cardiovasc Med. 2022; 9:839379. PMC: 9008259. DOI: 10.3389/fcvm.2022.839379. View